Thiel-backed psychedelics startup Atai valued at over $3 bln in Nasdaq debut
June 18 (Reuters) - Shares of Atai Life Sciences B.V.,
backed by billionaire investor Peter Thiel, jumped 40% in their
U.S. stock market debut on Friday, giving the German
psychedelics startup a market capitalization of $3.19 billion.
(Reporting by Sohini Podder and Niket Nishant in Bengaluru;
Editing by Devika Syamnath)
((sohini.podder@thomsonreuters.com;))
Recent news on AtaiBeckley
See all newsFDA to hold public hearing on psychedelic drugs as Trump-driven push gathers pace
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM